Zeldox Bold Interaction Warning, Not Black Box, Needed For QTc - Committee
• By The Pink Sheet
Labeling for Pfizer's Zeldox (ziprasidone) should clearly warn against combination use with other drugs that may prolong the QTc interval, but a black box may not be necessary, FDA's Psychopharmacological Drugs Advisory Committee suggested July 19.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
